Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies

Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies

This report presents a case of a neurofascin-155 (NF155)+ autoimmune nodopathy (AN) patient who exhibited resistance to conventional treatments but responded positively to telitacicept therapy. Telitacicept, a dual inhibitor of B lymphocyte stimulator (BLyS) and A proliferation-inducing ligand (APRI...

Full description

Bibliographic Details
Main Authors: Yijun Ren, Si Chen, Huan Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Immunology
Subjects:
autoimmune nodopathy
telitacicept
neurofascin-155
plasma cells
treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1279808/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1279808/full

Similar Items